Press release
Progressive Supranuclear Palsy-Pipeline Review H1 2017
Progressive supranuclear palsy, also called Steele-Richardson-Olszewski syndrome is a rare neurodegenerative disease that leads to difficulty with balance, movement, vision, speech and swallowing. Symptoms include fatigue, headaches, dizziness, depression, Parkinsonism, behavioral, cognitive, and gait disturbances that cause imbalance and arthralgias. The only proven risk factor for progressive supranuclear palsy is age. Treatment includes anticholinergic medications.
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide Progressive Supranuclear Palsy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Progressive Supranuclear Palsy (Central Nervous System) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Find More Information@ http://www.reportsweb.com/progressive-supranuclear-palsy-pipeline-review-h1-2017
The Progressive Supranuclear Palsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Progressive Supranuclear Palsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 3, 4, 1, 2, 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Progressive Supranuclear Palsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Request Sample Report@ http://www.reportsweb.com/inquiry&RW0001834402/sample
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
List of Tables
Number of Products under Development for Progressive Supranuclear Palsy, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Progressive Supranuclear Palsy - Pipeline by AB Science SA, H1 2017
Progressive Supranuclear Palsy - Pipeline by AbbVie Inc, H1 2017
Progressive Supranuclear Palsy - Pipeline by AlzProtect SAS, H1 2017
Progressive Supranuclear Palsy - Pipeline by Asceneuron SA, H1 2017
Progressive Supranuclear Palsy - Pipeline by Bristol-Myers Squibb Company, H1 2017
Progressive Supranuclear Palsy - Pipeline by Cortice Biosciences Inc, H1 2017
Progressive Supranuclear Palsy - Pipeline by Intellect Neurosciences Inc, H1 2017
Progressive Supranuclear Palsy - Pipeline by K-Stemcell Co Ltd, H1 2017
Progressive Supranuclear Palsy - Pipeline by Merck & Co Inc, H1 2017
Progressive Supranuclear Palsy - Pipeline by Prana Biotechnology Ltd, H1 2017
Progressive Supranuclear Palsy - Pipeline by TauRx Therapeutics Ltd, H1 2017
Progressive Supranuclear Palsy - Dormant Projects, H1 2017
Buy This Report@ http://www.reportsweb.com/buy&RW0001834402/buy/2000
List of Figures
Number of Products under Development for Progressive Supranuclear Palsy, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Molecule Types, H1 2017
Number of Products by Stage and Molecule Types, H1 2017
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Progressive Supranuclear Palsy-Pipeline Review H1 2017 here
News-ID: 747030 • Views: …
More Releases from ReportsWeb
North America: Smart Airport Market Overall Study Report 2020-2026| Amadeus IT G …
The "Global North America Smart Airport Market: 2020" Industry Report is a professional and in-depth study on the current state of the North America Smart Airport Market by PMR. The North America Smart Airport market is supposed to demonstrate a considerable growth during the forecast period of 2020 - 2026. The company profiles of all the key players and brands that are dominating the market have been given in this…
Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such …
ReportsWeb.com has announced the addition of the “Marine Biotechnology-Global Market Outlook 2017-2026” The report classifies the global Marine Biotechnology Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
According to Publisher, the Global Marine Biotechnology Market is accounted for $3.93 billion in 2017 and is expected to reach $8.74 billion by 2026 growing at a CAGR of 9.3% during…
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by …
ReportsWeb.com has announced the addition of the “Anti-Counterfeiting Packaging-Global Market Outlook 2017-2026” The report classifies the global Anti-Counterfeiting Packaging Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
According to Publisher, the Global Anti-Counterfeiting Packaging Market is accounted for $112.16 billion in 2017 and is expected to reach $427.96 billion by 2026 growing at a CAGR of 16.0% during…
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Hol …
Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles
Summary
"Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Italy.
The report provides in depth analysis on global renewable power market and…
More Releases for Progressive
Progressive Supranuclear Palsy Headed Toward Cure
Progressive supranuclear palsy (PSP) is a brain disorder which impacts vision, cognition, movement, and speech. This disease results in weakness by affecting certain parts of the brain above the cell clusters, known as nuclei (supranuclear), which are involved in controlling eye movements. It usually manifests in mid-to late adulthood, and the survival rate of people suffering from PSP is five to nine years after the disease first appears. It is…
Primary Progressive MS – Strong pipeline in progressive MS indicates a paradig …
Multiple Sclerosis is an autoimmune disorder that happens in the Central nervous system of the body. Multiple Sclerosis involves the brain, optic nerves and the spinal cord and leads to the destruction of the insulation layer, Myelin, which covers the nerve fibers in the CNS.
Primary progressive multiple sclerosis is primarily characterized by progression of disease activity and the disability amongst the patients. As per the latest report by Pharmascroll, PPMS-…
Catalyst Market Anticipated for Progressive Growth
The global Catalyst market was worth USD 29.28 billion in the year 2016 and is anticipated to reach roughly USD 40.92 billion by 2025, while registering itself at a compound annual growth rate (CAGR) of 3.79% during the forecast period. Catalyst is known to be an element that increases the rate of chemical reaction without undertaking any kind of chemical change itself. Generally, reactions take place rapidly by utilizing catalysts…
Neurorehabilitation Devices Market Anticipated for Progressive Growth
Neurorehabilitation helps improve the patient’s ability to function independently after he is diagnosed with conditions such as stroke, multiple sclerosis, brain tumor, Parkinson’s disease, epilepsy and traumatic brain injury among other neurological disorders. Neurorehabilitation is a multi-modal, multi-disciplinary approach to help such patients to improve their physiological functioning. Neurorehabilitation can be broadly classified into three coordinated phases, viz. intermediate care, acute rehabilitation and occupational rehabilitation. Patients undergoing neurorehabilitation usually go…
Progressive Personnel rebrands to Progressive Travel Recruitment
Global travel and hospitality recruitment leader, Progressive Personnel, this month re-emerges as Progressive Travel Recruitment with a fresh new look and a new website under the new URL – www.progressivetravelrecruitment.com – with enhanced job search capability.
Progressive Travel Recruitment’s competitive edge, however, remains – a dedicated team of specialist travel recruiters, who have themselves worked in the industry and understand intimately the needs of travel companies and travel candidates, and…
The Progressive Approach to Golf Improvement
"A Groundbreaking Approach For Golfers To Apply Their Golf Instruction With A Unique Improvement Plan For Lower Golf Scores" By Australian PGA Professional, Doug Kercher
A triple set of a new golf instruction books called "Golf - Your Perfect Plan For Practice And Play" by Doug Kercher, Australian PGA Professional is now available. Every part of golf from goal setting to practice schedules to analyzing golf rounds is explained in…
